Startseite>>Signaling Pathways>> Others>>5’-Phosphoguanylyl-(3’,5’)-guanosine

5’-Phosphoguanylyl-(3’,5’)-guanosine

Katalog-Nr.GC63957

5’-Phosphoguanylyl-(3’,5’)-Guanosin (pGpG) ist ein intermediäres Molekül, das auf dem Weg des enzymatischen Abbaus von zyklischem Diguanylat (c-di-GMP) entsteht.

Products are for research use only. Not for human use. We do not sell to patients.

5’-Phosphoguanylyl-(3’,5’)-guanosine Chemische Struktur

Cas No.: 33008-99-0

Größe Preis Lagerbestand Menge
1 mg
189,00 $
Auf Lager
5 mg
432,00 $
Auf Lager
10 mg
612,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

5’-Phosphoguanylyl-(3’,5’)-guanosine (pGpG) is an intermediate molecule produced by the pathway for enzymatic cyclic diguanylate (c-di-GMP) degradation. 5’-Phosphoguanylyl-(3’,5’)-guanosine can be used to detect the metabolism of nucleic acids[1][2].

5’-Phosphoguanylyl-(3’,5’)-guanosine reduces the rate of c-di-GMP degradation in cell lysates and inhibits the activity of EAL-dependent PDEs (PA2133, PvrR, and purified recombinant RocR) from P. aeruginosa[2].

[1]. Nesbitt NM, et, al. Modification of a bi-functional diguanylate cyclase-phosphodiesterase to efficiently produce cyclic diguanylate monophosphate. Biotechnol Rep (Amst). 2015 May 5;7:30-37.
[2]. Cohen D, et, al. Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11359-64.

Bewertungen

Review for 5’-Phosphoguanylyl-(3’,5’)-guanosine

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5’-Phosphoguanylyl-(3’,5’)-guanosine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.